Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 21;23(2):10.
doi: 10.1007/s11886-020-01435-6.

Role of Clinical Genetic Testing in the Management of Aortopathies

Affiliations
Review

Role of Clinical Genetic Testing in the Management of Aortopathies

Stephanie L Harris et al. Curr Cardiol Rep. .

Abstract

Purpose of review: Thoracic aortic aneurysms (TAA) have a strong heritable basis, and identification of a genetic etiology has important implications for patients with TAA and their relatives. This review provides an overview of Mendelian causes of TAA, discusses important considerations for genetic testing, and summarizes the impact a genetic diagnosis may have on a patient's medical care.

Recent findings: Thoracic aortic disease may be non-syndromic or seen as part of a genetic syndrome, such as Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syndrome. Expanded access to genetic testing has revealed the wide and overlapping phenotypic spectrum of these conditions, highlighting the need for genetic testing to establish an accurate diagnosis. Important aspects of genetic evaluation include thorough phenotyping through family history and physical examination, selection of an appropriate genetic test driven by the patient's phenotype, and careful interpretation of genetic test results. Improved understanding of the natural history of these conditions has led to tailored management recommendations, including gene-based recommendations for prophylactic surgical repair. Identification of a genetic etiology allows for careful monitoring of disease progression, informs the timing of prophylactic surgical repair, and facilitates the identification of other at-risk relatives through cascade genetic testing.

Keywords: Aortopathy; Genetic counseling; Genetic testing; Marfan syndrome.

PubMed Disclaimer

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. Ito S, Akutsu K, Tamori Y, Sakamoto S, Yoshimuta T, Hashimoto H, et al. Differences in atherosclerotic profiles between patients with thoracic and abdominal aortic aneurysms. Am J Cardiol. 2008;101(5):696–9. https://doi.org/10.1016/j.amjcard.2007.10.039 . - DOI - PubMed
    1. Hemminki K, Li X, Johansson SE, Sundquist K, Sundquist J. Familial risks of aortic aneurysms among siblings in a nationwide Swedish study. Genet Med. 2006;8(1):43–9. https://doi.org/10.1097/01.gim.0000195973.60136.48 . - DOI - PubMed
    1. Rigelsky CM, Moran RT. Genetics of syndromic and nonsyndromic aortopathies. Curr Opin Pediatr. 2019;31(6):694–701. https://doi.org/10.1097/MOP.0000000000000836 . - DOI - PubMed
    1. Tiecke F, Katzke S, Booms P, Robinson PN, Neumann L, Godfrey M, et al. Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype-phenotype correlations in FBN1 exons 24-40. Eur J Hum Genet. 2001;9(1):13–21. https://doi.org/10.1038/sj.ejhg.5200582 . - DOI - PubMed
    1. Takeda N, Inuzuka R, Maemura S, Morita H, Nawata K, Fujita D, et al. Impact of pathogenic FBN1 variant types on the progression of aortic disease in patients with Marfan syndrome. Circ Genomic Precis Med. 2018;11(6):e002058. https://doi.org/10.1161/CIRCGEN.117.002058 . - DOI

MeSH terms

LinkOut - more resources